Literature DB >> 33659549

In vivo Tumor Growth and Spontaneous Metastasis Assays Using A549 Lung Cancer Cells.

Lei Qi1, Teresa Knifley1, Dava W Piecoro2, Piotr Rychahou1,3, Jianrong Wu1,4, Kathleen L O'Connor1,5, Min Chen1,6.   

Abstract

Metastasis accounts for the majority of cancer related deaths. The genetically engineered mouse (GEM) models and cell line-based subcutaneous and orthotopic mouse xenografts have been developed to study the metastatic process. By using lung cancer cell line A549 as an example, we present a modified protocol to establish the cell line-based xenograft. Our protocol ensures sufficient establishment of the mouse xenografts and allows us to monitor tumor growth and spontaneous metastasis. This protocol could be adapted to other types of established cancer cell lines or primary cancer cells to study the mechanism of metastatic process as well as to test the effect of the potential anti-cancer agents on tumor growth and metastatic capacity.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Cell line xenograft; Implantation; Metastasis rate; Mouse; Patient-derived xenograft; Tumor growth

Year:  2020        PMID: 33659549      PMCID: PMC7842773          DOI: 10.21769/BioProtoc.3579

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  11 in total

Review 1.  Molecular determinants of lung cancer metastasis to the central nervous system.

Authors:  Timothy G Whitsett; Landon J Inge; Harshil D Dhruv; Philip Y Cheung; Glen J Weiss; Ross M Bremner; Jeffrey A Winkles; Nhan L Tran
Journal:  Transl Lung Cancer Res       Date:  2013-08

2.  S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.

Authors:  Lili Liu; Lei Qi; Teresa Knifley; Dava W Piecoro; Piotr Rychahou; Jinpeng Liu; Mihail I Mitov; Jeremiah Martin; Chi Wang; Jianrong Wu; Heidi L Weiss; D Allan Butterfield; B Mark Evers; Kathleen L O'Connor; Min Chen
Journal:  J Biol Chem       Date:  2019-03-18       Impact factor: 5.157

Review 3.  Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.

Authors:  Chiara D'Antonio; Antonio Passaro; Bruno Gori; Ester Del Signore; Maria Rita Migliorino; Serena Ricciardi; Alberto Fulvi; Filippo de Marinis
Journal:  Ther Adv Med Oncol       Date:  2014-05       Impact factor: 8.168

4.  Establishment of human tumor xenografts in immunodeficient mice.

Authors:  Christopher L Morton; Peter J Houghton
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 5.  Mouse models of lung cancer.

Authors:  Amit Dutt; Kwok-Kin Wong
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

Review 6.  Modeling metastasis in vivo.

Authors:  Chand Khanna; Kent Hunter
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

7.  A genetic mouse model for metastatic lung cancer with gender differences in survival.

Authors:  S Zheng; A K El-Naggar; E S Kim; J M Kurie; G Lozano
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

8.  Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics.

Authors:  Verline Justilien; Alan P Fields
Journal:  Curr Protoc Pharmacol       Date:  2013-10-08

Review 9.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

Review 10.  Mouse models of metastasis: progress and prospects.

Authors:  Laura Gómez-Cuadrado; Natasha Tracey; Ruoyu Ma; Binzhi Qian; Valerie G Brunton
Journal:  Dis Model Mech       Date:  2017-09-01       Impact factor: 5.758

View more
  1 in total

1.  An Unrevealed Molecular Function of Corannulene Buckybowl Glycoconjugates in Selective Tumor Annihilation by Targeting the Cancer-Specific Warburg Effect.

Authors:  Shengnan Liu; Ziru Sun; Min Liang; Weijie Song; Ru Zhang; Yunli Shi; Yujun Cui; Qingzhi Gao
Journal:  Adv Sci (Weinh)       Date:  2022-03-07       Impact factor: 16.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.